Jeffs’ Brands Launches Sales of Pest Control Brands on the

Jeffs’ Brands Launches Sales of Pest Control Brands on the

Expands the brands' reach to Amazon’s most dominant territory Tel Aviv, Israel, March 15, 2023 (GLOBE NEWSWIRE) -- Jeffs' Brands Ltd (“Jeffs’ Brands”......

Werewolf Therapeutics Announces Upcoming Presentation at

Werewolf Therapeutics Announces Upcoming Presentation at

CAMBRIDGE, Mass., March 15, 2023 (GLOBE NEWSWIRE) -- Werewolf Therapeutics, Inc. (the “Company” or “Werewolf”) (Nasdaq: HOWL), an innovative......

REE Automotive Appoints New Chief Financial Officer,

REE Automotive Appoints New Chief Financial Officer,

TEL-AVIV, Israel, March 15, 2023 (GLOBE NEWSWIRE) -- GlobeNewswire – REE Automotive Ltd. (Nasdaq: REE), an automotive technology company and provider of......

ObsEva Announces Progress Towards its Plans to Consolidate

ObsEva Announces Progress Towards its Plans to Consolidate

Ad hoc announcement pursuant to Art. 53 LR of the SIX Swiss Exchange GENEVA, Switzerland – March 15, 2023 – ObsEva SA (NASDAQ: OBSV; SIX: OBSN), a......

Kingsoft Cloud to Report Fourth Quarter and Fiscal Year

Kingsoft Cloud to Report Fourth Quarter and Fiscal Year

BEIJING, March 15, 2023 (GLOBE NEWSWIRE) -- Kingsoft Cloud Holdings Limited (NASDAQ: KC and HKEX: 3896) (“Kingsoft Cloud” or the “Company”), a leading......

RVL Pharmaceuticals plc to Discuss Fourth Quarter and Full

RVL Pharmaceuticals plc to Discuss Fourth Quarter and Full

Conference call to be held Monday, March 20, 2023, at 8:30 a.m. ET......

Array Technologies, Inc. Announces Updated Earnings Release

Array Technologies, Inc. Announces Updated Earnings Release

ALBUQUERQUE, N.M., March 15, 2023 (GLOBE NEWSWIRE) -- Today Array Technologies (NASDAQ: ARRY) (“Array” or “the Company”), a leading provider of tracker......

Tango Therapeutics to Highlight Preclinical Data on

Tango Therapeutics to Highlight Preclinical Data on

BOSTON, March 14, 2023 (GLOBE NEWSWIRE) -- Tango Therapeutics, Inc. (NASDAQ: TNGX) today announced the acceptance of two oral and two poster......

Harpoon Therapeutics Announces Acceptance of Five Abstracts

Harpoon Therapeutics Announces Acceptance of Five Abstracts

Preclinical abstracts for investigational T cell engagers, HPN328 and HPN217, in mouse models provide further validation of Harpoon’s proprietary......

Kinnate Biopharma Inc. to Report First Clinical Data for

Kinnate Biopharma Inc. to Report First Clinical Data for

Company has initiated enrollment of patients into the monotherapy expansion cohorts Company to host a virtual investor webcast on April 17, 2023, to......

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • ...
  • 44
  • menu
    menu